Pacific Biosciences Of California (PACB) Raw Materials (2011 - 2026)

Pacific Biosciences Of California's Raw Materials history runs 16 years deep, the most recent figure standing at $34.7 million for Q1 2026.

• In Q1 2026, Raw Materials fell 21.9% year-over-year to $34.7 million; the TTM figure through Mar 2026 stood at $34.7 million (down 21.9% YoY), while the FY2025 annual figure was $38.6 million, down 14.65% from the prior year.
• Raw Materials was $34.7 million for Q1 2026 at Pacific Biosciences Of California, down from $38.6 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $46.0 million in Q2 2025 to a low of $11.5 million in Q1 2022.
• Historically, Raw Materials has averaged $30.2 million across 5 years, with a median of $29.9 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Raw Materials surged 202.0% in 2022, then slipped 21.9% in 2026.
• A 5-year view of Raw Materials shows it stood at $24.1 million in 2022, then surged by 34.36% to $32.4 million in 2023, then soared by 39.58% to $45.3 million in 2024, then fell by 14.65% to $38.6 million in 2025, then slipped by 10.1% to $34.7 million in 2026.
• The last three Raw Materials figures came in at $34.7 million (Q1 2026), $38.6 million (Q4 2025), and $41.8 million (Q3 2025), per Business Quant data.